HD-OPM Archive
Topics › LDL, ApoB & lipid panel

HDL is a poor intervention target: every large HDL-raising trial has failed

Louis Nervegna · Jul 28, 2025 · ♥ 9 reactions · 12 comments · original Facebook post
LDL, ApoB & lipid panelHow to read research
AI summary & key facts

Louis argues HDL is basically only a crude marker of insulin resistance and notes every large randomized trial of HDL-raising has failed to prevent heart attacks and strokes. A shared post adds that Mendelian randomization found no benefit of genetically high HDL.

HDL is basically useless as an intervention target in CVD, except as a crude marker of insulin resistance. And there are far more accurate ways to measure insulin resistance than using HDL, e.g. an oral glucose tolerance test which also measures insulin.

Every single large randomized trial testing HDL-raising as an intervention has failed to prevent heart attacks and strokes. Literally every single one. It has a perfect track record of failure in cardiology.

It is good to have higher HDL for the same reason that it is good to have better insulin sensitivity. That’s about the only evidence-based thing you can say about HDL as an intervention target in cardiology.

The focus should be on improving insulin sensitivity, not on HDL.

(If you focus on inproving insulin sensitivity, the HDL will likely go up naturally as a side effect.)

References on HDL:

↪ HDL and ApoA-I raising therapies repeatedly failed, so HDL is probably not directly causal

↪ CSL112 ApoA-I infusion failed in phase 3 AEGIS-II, supporting HDL as marker not cause

↪ Low HDL matters mainly through insulin resistance; raising HDL itself failed in trials

↪ TG/HDL, insulin resistance and LDL: both are independent causes of heart disease

↪ TG/HDL ratio tracks visceral fat; clearing liver and pancreas fat improves it

↪ Why insulin resistance lowers HDL, and why improving insulin sensitivity beats chasing HDL

↪ Interview: insulin resistance and LDL/ApoB are both independent causes of heart disease

#hdlHD #tghdlratioHD

It is getting harder and harder to help people. The amount of terrible advice being passed around by so called "experts" who clearly haven't even read any good info on the subject they are advising people about is staggering and getting worse.

For starters, all studies to date trying various ways to raise HDL in order to reduce risk of ASCVD have failed miserably. Plus mendelian randomization and genetic studies have found that people with lifelong elevated HDL-C due to certain genetic variants did not have lower risk for heart attack. Even direct infusions of HDL into people's blood streams don't help lower risk. Actively raising HDL simply doesn't help lower risk.

The goal here should NOT be to "raise HDL", it should be to lower LDL and triglycerides.

Great?!? These labs are far from great.

Ugh.

No photo description available.No photo description available.
← newer: HDL-raising trials all failed: torcetrapib, dalcetrapib, evaolder: Low vitamin D may contribute to statin muscle pain; suppleme →